Viral Bcl-2 homologs and their role in virus replication and associated diseases

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1644, Issue 2-3, 2004, Pages 211-227

  Polster, Brian M ^a   Pevsner, Jonathan ^b   Hardwick, J Marie ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Adenovirus; Apoptosis; Bcl 2; Epstein Barr; Gamma herpesvirus; Kaposi's sarcoma

Indexed keywords

PROTEIN BCL 2;

ADENOVIRUS; APOPTOSIS; BIOAVAILABILITY; CANCER; CELL DEATH; DISEASE ASSOCIATION; DNA VIRUS; GENETIC CODE; HERPES VIRUS; HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

APOPTOSIS; DIMERIZATION; HUMANS; ONCOGENE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; VIRAL PROTEINS; VIRUS DISEASES; VIRUS REPLICATION;

ADENOVIRIDAE; DNA VIRUSES; HERPESVIRIDAE; MAMMALIA;

EID: 1442301767     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2003.11.001     Document Type: Review

References (186)

1. Roulston A., Marcellus R.C., Branton P.E. Viruses and apoptosis. Annu. Rev. Microbiol. 53:1999;577-628.
2. Newmeyer D.D., Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 112:2003;481-490.
3. Benedict C.A., Norris P.S., Ware C.F. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:2002;1013-1018.
4. Cuconati A., White E. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev. 16:2002;2465-2478.
5. Hardwick J.M., Bellows D.S. Viral versus cellular BCL-2 proteins. Cell Death Differ. 1:2003;S68-S76.
6. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev., Cancer. 2:2002;647-656.
7. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
8. Bateman A., Birney E., Cerruti L., Durbin R., Etwiller L., Eddy S.R., Griffiths-Jones S., Howe K.L., Marshall M., Sonnhammer E.L. The Pfam protein families database. Nucleic Acids Res. 30:2002;276-280.
9. Chiou S.K., Tseng C.C., Rao L., White E. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:1994;6553-6566.
10. Goldmacher V.S., Bartle L.M., Skaletskaya A., Dionne C.A., Kedersha N.L., Vater C.A., Han J.W., Lutz R.J., Watanabe S., Cahir McFarl E.D., Kieff E.D., Mocarski E.S., Chittenden T. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12536-12541.
11. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097-1099.
12. Pegoraro L., Palumbo A., Erikson J., Falda M., Giovanazzo B., Emanuel B.S., Rovera G., Nowell P.C., Croce C.M. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 81:1984;7166-7170.
13. Tsujimoto Y., Cossman J., Jaffe E., Croce C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1985;1440-1443.
14. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger U., McKearn J.P., Korsmeyer S.J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57:1989;79-88.
15. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 80:1992;879-886.
16. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
17. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
18. Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19-28.
19. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. U. S. A. 90:1993;8479-8483.
20. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
21. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., Oltvai Z.N. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4:1993;327-332.
22. Hsu Y.T., Youle R.J. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272:1997;13829-13834.
23. Cheng E.H., Levine B., Boise L.H., Thompson C.B., Hardwick J.M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature. 379:1996;554-556.
24. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
25. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
26. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
27. 2+ ions. J. Cell Biol. 143:1998;217-224.
28. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4997-5002.
29. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
30. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
31. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20:2000;929-935.
32. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., Martinou J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:1999;891-901.
33. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2000;2060-2071.
34. Saito M., Korsmeyer S.J., Schlesinger P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell Biol. 2:2000;553-555.
35. Kuwana T., MacKey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 111:2002;331-342.
36. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:2001;11615-11623.
37. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
38. Ottilie S., Diaz J.L., Horne W., Chang J., Wang Y., Wilson G., Chang S., Weeks S., Fritz L.C., Oltersdorf T. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem. 272:1997;30866-30872.
39. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730.
40. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.
41. Ruffolo S.C., Shore G.C. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 27:2003;25039-25045.
42. Perez D., White E. TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell. 6:2000;53-63.
43. Sundararajan R., White E. E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J. Virol. 75:2001;7506-7516.
44. Cuconati A., Degenhardt K., Sundararajan R., Anschel A., White E. Bak and Bax function to limit adenovirus replication through apoptosis induction. J. Virol. 76:2002;4547-4558.
45. Sundararajan R., Cuconati A., Nelson D., White E. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J. Biol. Chem. 276:2001;45120-45127.
46. Hsu Y.T., Youle R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273:1998;10777-10783.
47. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S.A., Mannella C.A., Korsmeyer S.J. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell. 2:2002;55-67.
48. Han J., Sabbatini P., White E. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:1996;5857-5864.
49. Boyd J.M., Gallo G.J., Elangovan B., Houghton A.B., Malstrom S., Avery B.J., Ebb R.G., Subramanian T., Chittenden T., Lutz R.J.et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1995;1921-1928.
50. Boyd J.M., Malstrom S., Subramanian T., Venkatesh L.K., Schaeper U., Elangovan B., D'Sa-Eipper C., Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 79:1994;341-351.
51. Farrow S.N., White J.H., Martinou I., Raven T., Pun K.T., Grinham C.J., Martinou J.C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733.
52. Chen G., Branton P.E., Yang E., Korsmeyer S.J., Shore G.C. Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271:1996;24221-24225.
53. Han J., Sabbatini P., Perez D., Rao L., Modha D., White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:1996;461-477.
54. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Chang B.S., Thompson C.B., Wong S.L., Ng S.L., Fesik S.W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
55. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.C. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:1997;370-372.
56. Antonsson B., Montessuit S., Lauper S., Eskes R., Martinou J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J. 345(Pt 2):2000;271-278.
57. Pavlov E.V., Priault M., Pietkiewicz D., Cheng E.H., Antonsson B., Manon S., Korsmeyer S.J., Mannella C.A., Kinnally K.W. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J. Cell Biol. 155:2001;725-731.
58. Roucou X., Rostovtseva T., Montessuit S., Martinou J.C., Antonsson B. Bid induces cytochrome c-impermeable Bax channels in liposomes. Biochem. J. 363:2002;547-552.
59. Schlesinger P.H., Gross A., Yin X.M., Yamamoto K., Saito M., Waksman G., Korsmeyer S.J. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11357-11362.
60. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., Fill M., Thompson C.B. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
61. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5113-5118.
62. Schendel S.L., Azimov R., Pawlowski K., Godzik A., Kagan B.L., Reed J.C. Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem. 274:1999;21932-21936.
63. Brenner C., Cadiou H., Vieira H.L., Zamzami N., Marzo I., Xie Z., Leber B., Andrews D., Duclohier H., Reed J.C., Kroemer G. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene. 19:2000;329-336.
64. Shimizu S., Ide T., Yanagida T., Tsujimoto Y. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J. Biol. Chem. 275:2000;12321-12325.
65. Vander Heiden M.G., Li X.X., Gottleib E., Hill R.B., Thompson C.B., Colombini M. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J. Biol. Chem. 276:2001;19414-19419.
66. Hardwick J.M., Polster B.M. Bax, along with lipid conspirators, allows cytochrome c to escape mitochondria. Mol. Cell. 10:2002;963-965.
67. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L., Prevost M.C., Xie Z., Matsuyama S., Reed J.C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
68. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14681-14686.
69. 2+: a control point for apoptosis. Science. 300:2003;135-139.
70. Zong W.X., Li C., Hatzivassiliou G., Lindsten T., Yu Q.C., Yuan J., Thompson C.B. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 162:2003;59-69.
71. Lewis J., Oyler G.A., Ueno K., Fannjiang Y.R., Chau B.N., Vornov J., Korsmeyer S.J., Zou S., Hardwick J.M. Inhibition of virus-induced neuronal apoptosis by Bax. Nat. Med. 5:1999;832-835.
72. Fannjiang Y., Kim C.H., Huganir R.L., Zou S., Lindsten T., Thompson C.B., Mito T., Traystman R.J., Larsen T., Griffin D.E., Mandir A.S., Dawson T.M., Dike S., Sappington A.L., Kerr D.A., Jonas E.A., Kaczmarek L.K., Hardwick J.M. BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev. Cell. 4:2003;575-585.
73. Jonas E.A., Hoit D., Hickman J.A., Brandt T.A., Polster B.M., Fannjiang Y., McCarthy E., Montanez M.K., Hardwick J.M., Kaczmarek L.K. Modulation of synaptic transmission by the BCL-2 family protein BCL-xL. J. Neurosci. 23:2003;8423-8431.
74. Matsuyama S., Schendel S.L., Xie Z., Reed J.C. Cytoprotection by Bcl-2 requires the pore-forming alpha5 and alpha6 helices. J. Biol. Chem. 273:1998;30995-31001.
75. Vander Heiden M.G., Chandel N.S., Li X.X., Schumacker P.T., Colombini M., Thompson C.B. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4666-4671.
76. Danial N.N., Gramm C.F., Scorrano L., Zhang C.Y., Krauss S., Ranger A.M., Datta S.R., Greenberg M.E., Licklider L.J., Lowell B.B., Gygi S.P., Korsmeyer S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature. 424:2003;952-956.
77. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., Yoon H.S., Shuker S.B., Chang B.S., Minn A.J., Thompson C.B., Fesik S.W. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:1997;983-986.
78. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
79. Revilla Y., Cebrian A., Baixeras E., Martinez C., Vinuela E., Salas M.L. Inhibition of apoptosis by the African swine fever virus Bcl-2 homologue: role of the BH1 domain. Virology. 228:1997;400-404.
80. Khanim F., Dawson C., Meseda C.A., Dawson J., Mackett M., Young L.S. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J. Gen. Virol. 78(Pt 11):1997;2987-2999.
81. Huang Q., Petros A.M., Virgin H.W., Fesik S.W., Olejniczak E.T. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3428-3433.
82. Petros A.M., Medek A., Nettesheim D.G., Kim D.H., Yoon H.S., Swift K., Matayoshi E.D., Oltersdorf T., Fesik S.W. Solution structure of the antiapoptotic protein bcl-2. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3012-3017.
83. Chou J.J., Li H., Salvesen G.S., Yuan J., Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell. 96:1999;615-624.
84. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 103:2000;645-654.
85. Hinds M.G., Lackmann M., Skea G.L., Harrison P.J., Huang D.C., Day C.L. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22:2003;1497-1507.
86. Denisov A.Y., Madiraju M.S., Chen G., Khadir A., Beauparlant P., Attardo G., Shore G.C., Gehring K. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J. Biol. Chem. 23:2003;21124-21128.
87. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.H., Youle R.J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153:2001;1265-1276.
88. Petros A.M., Nettesheim D.G., Wang Y., Olejniczak E.T., Meadows R.P., Mack J., Swift K., Matayoshi E.D., Zhang H., Thompson C.B., Fesik S.W. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9:2000;2528-2534.
89. Cheng E.H., Nicholas J., Bellows D.S., Hayward G.S., Guo H.G., Reitz M.S., Hardwick J.M. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. U. S. A. 94:1997;690-694.
90. Nava V.E., Cheng E.H., Veliuona M., Zou S., Clem R.J., Mayer M.L., Hardwick J.M. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:1997;4118-4122.
91. Huang Q., Petros A.M., Virgin H.W., Fesik S.W., Olejniczak E.T. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J. Mol. Biol. 332:2003;1123-1130.
92. McDonnell J.M., Fushman D., Milliman C.L., Korsmeyer S.J., Cowburn D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell. 96:1999;625-634.
93. Theodorakis P., D'Sa-Eipper C., Subramanian T., Chinnadurai G. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene. 12:1996;1707-1713.
94. Bellows D.S., Howell M., Pearson C., Hazlewood S.A., Hardwick J.M. Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J. Virol. 76:2002;2469-2479.
95. Cheng E.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
96. Clem R.J., Cheng E.H., Karp C.L., Kirsch D.G., Ueno K., Takahashi A., Kastan M.B., Griffin D.E., Earnshaw W.C., Veliuona M.A., Hardwick J.M. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. U. S. A. 95:1998;554-559.
97. Kerr D.A., Larsen T., Cook S.H., Fannjiang Y.R., Choi E., Griffin D.E., Hardwick J.M., Irani D.N. BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis. J. Virol. 76:2002;10393-10400.
98. Kirsch D.G., Doseff A., Chau B.N., Lim D.S., de Souza-Pinto N.C., Hansford R., Kastan M.B., Lazebnik Y.A., Hardwick J.M. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274:1999;21155-21161.
99. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M.R. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 17:1998;1268-1278.
100. Basanez G., Zhang J., Chau B.N., Maksaev G.I., Frolov V.A., Brandt T.A., Burch J., Hardwick J.M., Zimmerberg J. Pro-apoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J. Biol. Chem. 276:2001;31083-31091.
101. Yamamoto K., Ichijo H., Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19:1999;8469-8478.
102. Ojala P.M., Yamamoto K., Castanos-Velez E., Biberfeld P., Korsmeyer S.J., Makela T.P. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2:2000;819-825.
103. Deverman B.E., Cook B.L., Manson S.R., Niederhoff R.A., Langer E.M., Rosova I., Kulans L.A., Fu X., Weinberg J.S., Heinecke J.W., Roth K.A., Weintraub S.J. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 111:2002;51-62.
104. Bellows D.S., Chau B.N., Lee P., Lazebnik Y., Burns W.H., Hardwick J.M. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J. Virol. 74:2000;5024-5031.
105. Wang N.S., Unkila M.T., Reineks E.Z., Distelhorst C.W. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J. Biol. Chem. 276:2001;44117-44128.
106. Hardwick J.M. Cyclin' on the viral path to destruction. Nat. Cell Biol. 2:2000;E203-E204.
107. Lomonosova E., Subramanian T., Chinnadurai G. Requirement of BAX for efficient adenovirus-induced apoptosis. J. Virol. 76:2002;11283-11290.
108. Virgin H.W.t., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., Speck S.H. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:1997;5894-5904.
109. Wang G.H., Garvey T.L., Cohen J.I. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis. J. Gen. Virol. 80(Pt 10):1999;2737-2740.
110. Roy D.J., Ebrahimi B.C., Dutia B.M., Nash A.A., Stewart J.P. Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch. Virol. 145:2000;2411-2420.
111. Hsu Y.T., Wolter K.G., Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3668-3672.
112. Chau B.N., Cheng E.H., Kerr D.A., Hardwick J.M. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol. Cell. 6:2000;31-40.
113. Virgin H.W.t., Presti R.M., Li X.Y., Liu C., Speck S.H. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J. Virol. 73:1999;2321-2332.
114. Gangappa S., van Dyk L.F., Jewett T.J., Speck S.H., Virgin H.W.t. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195:2002;931-940.
115. Weck K.E., Dal Canto A.J., Gould J.D., O'Guin A.K., Roth K.A., Saffitz J.E., Speck S.H., Virgin H.W. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1997;1346-1353.
116. Dal Canto A.J., Virgin H.W.t., Speck S.H. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J. Virol. 74:2000;11304-11310.
117. van Dyk L.F., Virgin H.W.t., Speck S.H. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74:2000;7451-7461.
118. Ojala P.M., Tiainen M., Salven P., Veikkola T., Castanos-Velez E., Sarid R., Biberfeld P., Makela T.P. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res. 59:1999;4984-4989.
119. van Dyk L.F., Hess J.L., Katz J.D., Jacoby M., Speck S.H., Virgin H.I. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J. Virol. 73:1999;5110-5122.
120. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333.
121. Kirshner J.R., Staskus K., Haase A., Lagunoff M., Ganem D. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J. Virol. 73:1999;6006-6014.
122. Pearson G.R., Luka J., Petti L., Sample J., Birkenbach M., Braun D., Kieff E. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology. 160:1987;151-161.
123. Hardwick J.M., Lieberman P.M., Hayward S.D. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62:1988;2274-2284.
124. Hickish T., Robertson D., Clarke P., Hill M., di Stefano F., Clarke C., Cunningham D. Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res. 54:1994;2808-2811.
125. Kawanishi M. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J. Virol. 71:1997;3319-3322.
126. Kawanishi M., Tada-Oikawa S., Kawanishi S. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem. Biophys. Res. Commun. 297:2002;682-687.
127. Foghsgaard L., Jaattela M. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J. Virol. 71:1997;7509-7517.
128. Tarodi B., Subramanian T., Chinnadurai G. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology. 201:1994;404-407.
129. Marshall W.L., Yim C., Gustafson E., Graf T., Sage D.R., Hanify K., Williams L., Fingeroth J., Finberg R.W. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J. Virol. 73:1999;5181-5185.
130. Cox M.A., Leahy J., Hardwick J.M. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64:1990;313-321.
131. Austin P.J., Flemington E., Yandava C.N., Strominger J.L., Speck S.H. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 85:1988;3678-3682.
132. Bodescot M., Perricaudet M. Epstein-Barr virus mRNAs produced by alternative splicing. Nucleic Acids Res. 14:1986;7103-7114.
133. Lee M.A., Yates J.L. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro. J. Virol. 66:1992;1899-1906.
134. Marchini A., Tomkinson B., Cohen J.I., Kieff E. BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 65:1991;5991-6000.
135. Crawford D.H. Biology and disease associations of Epstein-Barr virus. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356:2001;461-473.
136. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:2002;431-441.
137. Nilsson K., Klein G. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv. Cancer Res. 37:1982;319-380.
138. Klein G., Lenoir G. Translocations involving Ig-locus-carrying chromosomes: a model for genetic transposition in carcinogenesis. Adv. Cancer Res. 37:1982;381-387.
139. Gregory C.D., Dive C., Henderson S., Smith C.A., Williams G.T., Gordon J., Rickinson A.B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 349:1991;612-614.
140. Rowe M., Peng-Pilon M., Huen D.S., Hardy R., Croom-Carter D., Lundgren E., Rickinson A.B. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J. Virol. 68:1994;5602-5612.
141. Finke J., Fritzen R., Ternes P., Trivedi P., Bross K.J., Lange W., Mertelsmann R., Dolken G. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood. 80:1992;459-469.
142. Hardwick J.M. Virus-induced apoptosis. Adv. Pharmacol. 41:1997;295-336.
143. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
144. Boshoff C., Weiss R.A. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356:2001;517-534.
145. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Sturzl M., Monini P. Biology of Kaposi's sarcoma. Eur. J. Cancer. 37:2001;1251-1269.
146. Sarid R., Sato T., Bohenzky R.A., Russo J.J., Chang Y. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med. 3:1997;293-298.
147. Sun R., Lin S.F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:1999;2232-2242.
148. Widmer I., Wernli M., Bachmann F., Gudat F., Cathomas G., Erb P. Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions. J. Virol. 76:2002;2551-2556.
149. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N.H., Tschachler E., Colombini S., Ensoli B., Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:1997;7963-7968.
150. Schulz T.F. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J. Antimicrob. Chemother. 45(Suppl. T3):2000;15-27.
151. Staskus K.A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D.J., Ganem D., Haase A.T. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:1997;715-719.
152. Takemori N., Riggs J.L., Aldrich C. Genetic studies with tumorigenic adenoviruses. I. Isolation of cytocidal (cyt) mutants of adenovirus type 12. Virology. 36:1968;575-586.
153. Pilder S., Logan J., Shenk T. Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52:1984;664-671.
154. White E., Grodzicker T., Stillman B.W. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol. 52:1984;410-419.
155. Takemori N., Cladaras C., Bhat B., Conley A.J., Wold W.S. cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide. J. Virol. 52:1984;793-805.
156. Subramanian T., Kuppuswamy M., Gysbers J., Mak S., Chinnadurai G. 19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J. Biol. Chem. 259:1984;11777-11783.
157. White E., Cipriani R., Sabbatini P., Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:1991;2968-2978.
158. Subramanian T., Chinnadurai G. Separation of the functions controlled by adenovirus 2 lp+ locus. Virology. 150:1986;381-389.
159. White E., Faha B., Stillman B. Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen. Mol. Cell. Biol. 6:1986;3763-3773.
160. Tarodi B., Subramanian T., Chinnadurai G. Functional similarity between adenovirus E1B 19K gene and Bcl-2 oncogene: mutant complementation and suppression of cell death induced by DNA damaging agents. Int. J. Oncol. 3:1993;467-472.
161. Subramanian T., Tarodi B., Chinnadurai G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ. 6:1995;131-137.
162. Subramanian T., Tarodi B., Govindarajan R., Boyd J.M., Yoshida K., Chinnadurai G. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene. 124:1993;173-181.
163. Lin H.J., Eviner V., Prendergast G.C., White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15:1995;4536-4544.
164. Martinou I., Fernandez P.A., Missotten M., White E., Allet B., Sadoul R., Martinou J.C. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J. Cell Biol. 128:1995;201-208.
165. White E., Sabbatini P., Debbas M., Wold W.S., Kusher D.I., Gooding L.R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:1992;2570-2580.
166. Sabbatini P., Chiou S.K., Rao L., White E. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1995;1060-1070.
167. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
168. Gooding L.R., Aquino L., Duerksen-Hughes P.J., Day D., Horton T.M., Yei S.P., Wold W.S. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J. Virol. 65:1991;3083-3094.
169. Hashimoto S., Ishii A., Yonehara S. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3:1991;343-351.
170. Huang D.C., Cory S., Strasser A. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14:1997;405-414.
171. Han J., Modha D., White E. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene. 17:1998;2993-3005.
172. Khaled A.R., Kim K., Hofmeister R., Muegge K., Durum S.K. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14476-14481.
173. Pawlowski J., Kraft A.S. Bax-induced apoptotic cell death. Proc. Natl. Acad. Sci. U. S. A. 97:2000;529-531.
174. Roucou X., Martinou J.C. Conformational change of Bax: a question of life or death. Cell Death Differ. 8:2001;875-877.
175. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V.M., Adelman D.M., Simon M.C., Ma A., Golden J.A., Evan G., Korsmeyer S.J., MacGregor G.R., Thompson C.B. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
176. Deckwerth T.L., Elliott J.L., Knudson C.M., Johnson E.M. Jr., Snider W.D., Korsmeyer S.J. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:1996;401-411.
177. Zhu H., Shen Y., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:1995;7960-7970.
178. Smith J.A., Pari G.S. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. J. Virol. 69:1995;1925-1931.
179. Hayajneh W.A., Colberg-Poley A.M., Skaletskaya A., Bartle L.M., Lesperance M.M., Contopoulos-Ioannidis D.G., Kedersha N.L., Goldmacher V.S. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology. 279:2001;233-240.
180. Boya P., Roques B., Kroemer G. New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J. 20:2001;4325-4331.
181. Belzacq A.S., Vieira H.L., Verrier F., Vandecasteele G., Cohen I., Prevost M.C., Larquet E., Pariselli F., Petit P.X., Kahn A., Rizzuto R., Brenner C., Kroemer G. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res. 63:2003;541-546.
182. Frank S., Gaume B., Bergmann-Leitner E.S., Leitner W.W., Robert E.G., Catez F., Smith C.L., Youle R.J. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell. 1:2001;515-525.
183. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., Santel A., Fuller M., Smith C.L., Youle R.J. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159:2002;931-938.
184. Breckenridge D.G., Stojanovic M., Marcellus R.C., Shore G.C. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J. Cell Biol. 160:2003;1115-1127.
185. McCormick A.L., Smith V.L., Chow D., Mocarski E.S. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J. Virol. 77:2003;631-641.
186. Starkov A.A., Polster B.M., Fiskum G. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J. Neurochem. 83:2002;220-228.